Literature DB >> 28084323

Movement disorders in 2016: Progress in Parkinson disease and other movement disorders.

Joseph Jankovic1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28084323     DOI: 10.1038/nrneurol.2016.204

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Parkinson's disease: 4 big questions.

Authors:  Sarah Deweerdt
Journal:  Nature       Date:  2016-10-27       Impact factor: 49.962

Review 2.  Dopamine depleters in the treatment of hyperkinetic movement disorders.

Authors:  Joseph Jankovic
Journal:  Expert Opin Pharmacother       Date:  2016-12       Impact factor: 3.889

3.  Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.

Authors:  Marcus M Unger; Jörg Spiegel; Klaus-Ulrich Dillmann; David Grundmann; Hannah Philippeit; Jan Bürmann; Klaus Faßbender; Andreas Schwiertz; Karl-Herbert Schäfer
Journal:  Parkinsonism Relat Disord       Date:  2016-08-26       Impact factor: 4.891

Review 4.  Nonmotor features of Parkinson's disease subtypes.

Authors:  Connie Marras; K Ray Chaudhuri
Journal:  Mov Disord       Date:  2016-02-10       Impact factor: 10.338

5.  A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor.

Authors:  W Jeffrey Elias; Nir Lipsman; William G Ondo; Pejman Ghanouni; Young G Kim; Wonhee Lee; Michael Schwartz; Kullervo Hynynen; Andres M Lozano; Binit B Shah; Diane Huss; Robert F Dallapiazza; Ryder Gwinn; Jennifer Witt; Susie Ro; Howard M Eisenberg; Paul S Fishman; Dheeraj Gandhi; Casey H Halpern; Rosalind Chuang; Kim Butts Pauly; Travis S Tierney; Michael T Hayes; G Rees Cosgrove; Toshio Yamaguchi; Keiichi Abe; Takaomi Taira; Jin W Chang
Journal:  N Engl J Med       Date:  2016-08-25       Impact factor: 91.245

6.  Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.

Authors:  Samuel Frank; Claudia M Testa; David Stamler; Elise Kayson; Charles Davis; Mary C Edmondson; Shari Kinel; Blair Leavitt; David Oakes; Christine O'Neill; Christina Vaughan; Jody Goldstein; Margaret Herzog; Victoria Snively; Jacquelyn Whaley; Cynthia Wong; Greg Suter; Joseph Jankovic; Joohi Jimenez-Shahed; Christine Hunter; Daniel O Claassen; Olivia C Roman; Victor Sung; Jenna Smith; Sarah Janicki; Ronda Clouse; Marie Saint-Hilaire; Anna Hohler; Denyse Turpin; Raymond C James; Ramon Rodriguez; Kyle Rizer; Karen E Anderson; Hope Heller; Alexis Carlson; Susan Criswell; Brad A Racette; Fredy J Revilla; Frederick Nucifora; Russell L Margolis; MaryJane Ong; Tilak Mendis; Neila Mendis; Carlos Singer; Monica Quesada; Jane S Paulsen; Thomas Brashers-Krug; Amanda Miller; Jane Kerr; Richard M Dubinsky; Carolyn Gray; Stewart A Factor; Elaine Sperin; Eric Molho; Mary Eglow; Sharon Evans; Rajeev Kumar; Christina Reeves; Ali Samii; Sylvain Chouinard; Monica Beland; Burton L Scott; Patrick T Hickey; Sherali Esmail; Wai Lun Alan Fung; Clare Gibbons; Lina Qi; Amy Colcher; Cory Hackmyer; Andrew McGarry; Kevin Klos; Mark Gudesblatt; Lori Fafard; Laura Graffitti; Daniel P Schneider; Rohit Dhall; Joanne M Wojcieszek; Kathrin LaFaver; Andrew Duker; Erin Neefus; Hilary Wilson-Perez; David Shprecher; Paola Wall; Karen A Blindauer; Lynn Wheeler; James T Boyd; Emily Houston; Eric S Farbman; Pinky Agarwal; Shirley W Eberly; Arthur Watts; Pierre N Tariot; Andrew Feigin; Scott Evans; Chris Beck; Constance Orme; Jon Edicola; Emily Christopher
Journal:  JAMA       Date:  2016-07-05       Impact factor: 56.272

7.  Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.

Authors:  Timothy R Sampson; Justine W Debelius; Taren Thron; Stefan Janssen; Gauri G Shastri; Zehra Esra Ilhan; Collin Challis; Catherine E Schretter; Sandra Rocha; Viviana Gradinaru; Marie-Francoise Chesselet; Ali Keshavarzian; Kathleen M Shannon; Rosa Krajmalnik-Brown; Pernilla Wittung-Stafshede; Rob Knight; Sarkis K Mazmanian
Journal:  Cell       Date:  2016-12-01       Impact factor: 41.582

Review 8.  Parkinson disease subtypes.

Authors:  Mary Ann Thenganatt; Joseph Jankovic
Journal:  JAMA Neurol       Date:  2014-04       Impact factor: 18.302

9.  Identification of TMEM230 mutations in familial Parkinson's disease.

Authors:  Han-Xiang Deng; Yong Shi; Yi Yang; Kreshnik B Ahmeti; Nimrod Miller; Cao Huang; Lijun Cheng; Hong Zhai; Sheng Deng; Karen Nuytemans; Nicola J Corbett; Myung Jong Kim; Hao Deng; Beisha Tang; Ziquang Yang; Yanming Xu; Piu Chan; Bo Huang; Xiao-Ping Gao; Zhi Song; Zhenhua Liu; Faisal Fecto; Nailah Siddique; Tatiana Foroud; Joseph Jankovic; Bernardino Ghetti; Daniel A Nicholson; Dimitri Krainc; Onur Melen; Jeffery M Vance; Margaret A Pericak-Vance; Yong-Chao Ma; Ali H Rajput; Teepu Siddique
Journal:  Nat Genet       Date:  2016-06-06       Impact factor: 38.330

10.  The diagnostic discrimination of cutaneous α-synuclein deposition in Parkinson disease.

Authors:  Christopher H Gibbons; Jennifer Garcia; Ningshan Wang; Ludy C Shih; Roy Freeman
Journal:  Neurology       Date:  2016-07-06       Impact factor: 9.910

  10 in total
  7 in total

1.  Phases of procedural learning and memory: characterisation with perceptual-motor sequence tasks.

Authors:  Jui-Yang Hong; Eden Gallanter; Eva M Müller-Oehring; Tilman Schulte
Journal:  J Cogn Psychol (Hove)       Date:  2019-07-14

Review 2.  Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.

Authors:  Nicki Niemann; Joseph Jankovic
Journal:  Drugs       Date:  2018-04       Impact factor: 9.546

Review 3.  Progress toward an integrated understanding of Parkinson's disease.

Authors:  Maxime W C Rousseaux; Joshua M Shulman; Joseph Jankovic
Journal:  F1000Res       Date:  2017-07-12

Review 4.  Extracellular Vesicles as Nanotherapeutics for Parkinson's Disease.

Authors:  Loredana Leggio; Greta Paternò; Silvia Vivarelli; Francesca L'Episcopo; Cataldo Tirolo; Gabriele Raciti; Fabrizio Pappalardo; Carmela Giachino; Salvatore Caniglia; Maria Francesca Serapide; Bianca Marchetti; Nunzio Iraci
Journal:  Biomolecules       Date:  2020-09-16

5.  Successful Treatment of Severe Tardive Dyskinesia with Valbenazine, Including a Patient's Perspective.

Authors:  Richard C Josiassen; Dawn M Filmyer; Jack Gillean; Syed Sikandar Shah; Tyler E Dietterich; Rita A Shaughnessy
Journal:  Am J Case Rep       Date:  2017-11-08

6.  Acupuncture protects from 6-OHDA-induced neuronal damage by balancing the ratio of DMT1/Fpn1.

Authors:  Lihong Li; Jun Lu; Yingying Sun; Xiaoqing Jin
Journal:  Saudi J Biol Sci       Date:  2019-07-13       Impact factor: 4.219

7.  LAG3 is not expressed in human and murine neurons and does not modulate α-synucleinopathies.

Authors:  Marc Emmenegger; Elena De Cecco; Marian Hruska-Plochan; Timo Eninger; Matthias M Schneider; Melanie Barth; Elena Tantardini; Pierre de Rossi; Mehtap Bacioglu; Rebekah G Langston; Alice Kaganovich; Nora Bengoa-Vergniory; Andrès Gonzalez-Guerra; Merve Avar; Daniel Heinzer; Regina Reimann; Lisa M Häsler; Therese W Herling; Naunehal S Matharu; Natalie Landeck; Kelvin Luk; Ronald Melki; Philipp J Kahle; Simone Hornemann; Tuomas P J Knowles; Mark R Cookson; Magdalini Polymenidou; Mathias Jucker; Adriano Aguzzi
Journal:  EMBO Mol Med       Date:  2021-07-26       Impact factor: 12.137

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.